Between November of last year and this past January, the FDA "cited 49 areas of concern, including a failure to follow good manufacturing practices" at Merck & Co. Inc's vaccine plant in Pennsylvania.
read more | digg story
skip to main |
skip to sidebar
Information for Manufacturers in Regulated Chemical Industries
